| Project/Area Number |
23790336
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
General medical chemistry
|
|---|
| Research Institution | Kobe University |
|---|
Principal Investigator |
IJUIN Takeshi 神戸大学, 大学院・医学研究科, 助教 (00361626)
|
|---|
| Project Period (FY) |
2011 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2011: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 骨格筋 / PI3キナーゼ / SKIP / IGF-1 / 筋量増強 / インスリン様増殖因子 / 糖尿病 / 筋萎縮 / タンパク質合成 |
|---|
| Research Abstract |
In this study, we revealed that skeletal muscle and kidney enriched inositol polyphosphate 5-phosphatase (SKIP) negatively regulated insulin-like growth factor (IGF)-1 signal in the skeletal muscle. SKIP inhibited IGF-1 mediated protein synthesis and hypertrophy through the negative regulation of PI 3-kinase signaling pathway. Together with the results that SKIP heterozygous knockout mice exhibited increased amount of tibialis anterior skeletal muscle, SKIP is likely to be a key factor that trigger hypotrophy of skeletal muscle. Thus, SKIP may be a promising target for the intervention of hypotrophy accompanied by several severe diseases including cancer cachexia.
|
